Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
54.10
+4.42 (8.90%)
At close: Oct 17, 2025, 4:00 PM EDT
54.25
+0.15 (0.28%)
After-hours: Oct 17, 2025, 7:48 PM EDT
Revolution Medicines Market Cap
Revolution Medicines has a market cap or net worth of $10.11 billion as of October 17, 2025. Its market cap has increased by 34.03% in one year.
Market Cap
10.11B
Enterprise Value
8.11B
1-Year Change
34.03%
Ranking
Category
Stock Price
$54.10
Market Cap Chart
Since February 13, 2020, Revolution Medicines's market cap has increased from $1.64B to $10.11B, an increase of 514.97%. That is a compound annual growth rate of 37.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2025 | 9.29B | 14.89% |
| Dec 31, 2024 | 8.08B | 71.26% |
| Dec 29, 2023 | 4.72B | 123.15% |
| Dec 30, 2022 | 2.11B | 14.03% |
| Dec 31, 2021 | 1.85B | -29.43% |
| Dec 31, 2020 | 2.63B | 59.81% |
| Feb 13, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 712.85B |
| Johnson & Johnson | 464.57B |
| AbbVie | 405.81B |
| UnitedHealth Group | 321.12B |
| AstraZeneca | 261.44B |
| Novo Nordisk | 254.14B |
| Novartis AG | 253.93B |
| Abbott Laboratories | 223.11B |